5-methylcytosine has been researched along with pixantrone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilardi, RA; Chiu, FC; Cutts, SM; Evison, BJ; Pezzoni, G; Phillips, DR | 1 |
1 other study(ies) available for 5-methylcytosine and pixantrone
| Article | Year |
|---|---|
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.
Topics: 5-Methylcytosine; Antibiotics, Antineoplastic; Cell Line, Tumor; CpG Islands; DNA Adducts; DNA Damage; DNA Methylation; DNA-Cytosine Methylases; Doxorubicin; Formaldehyde; Humans; Isoquinolines; Mass Spectrometry | 2009 |